Search

everythinglearnresearchcommunity

for

Search:↓

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

HuR is essential for Treg function and preventing autoimmunity.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.

Alopecia areata might help slow down certain cancers.

Smoking and alcohol are linked to early hair graying.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.